EARNEST Partners
STJ

EARNEST Partners’s St Jude Medical STJ Stock Holding History

EARNEST Partners’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-131
Closed -$11K – 1146
2016
Q4 		$11K Buy
+131
New +$10.4K ﹤0.01% 515

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

EARNEST Partners's STJ Position: Q1 2017 in Review

EARNEST Partners sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 131 shares — an estimated $11K sold.

EARNEST Partners first reported a position in STJ in Q4 2016 and held it in 1 quarter. The position peaked at $11K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • EARNEST Partners reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • EARNEST Partners sold 131 St Jude Medical shares in Q1 2017, an estimated $11K.
  • EARNEST Partners first reported a position in St Jude Medical in Q4 2016 and held it in 1 quarter.
  • EARNEST Partners's St Jude Medical position peaked at $11K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on EARNEST Partners's 13F filing for Q1 2017, filed 15 May 2017.